MDT vs TMO: fair value comparison
Medtronic plc and Thermo Fisher Scientific Inc. · Updated 2026-09-06
Both currently screen as fairly valued on TickrTrends' Forward Fair Value model. Within Healthcare, MDT currently sits closer to the top of our discount ranking.
| MDT | TMO | |
|---|---|---|
| Verdict | Fairly valued | Fairly valued |
| Last price | $94.17 | $613.78 |
| 12-month range | $73.98–$103.34 | $469.21–$600.50 |
| Sector rank | #64 of 113 Healthcare | #65 of 113 Healthcare |
| Quality grade | C | C |
| Leverage | Moderate | Moderate |
| Margin trend | Contracting | Stable |
| Revenue growth | Modest | Modest |
| RSI zone | Neutral | Neutral |
| DCF cross-check | Overvalued | Overvalued |
| 52-week position | The upper-middle quarter | The top quarter |
Full single-stock breakdowns: MDT fair value analysis · TMO fair value analysis